Violations of the breast milk substitutes act-2013 and its rules - 2017 in Bangladesh

S K Roy1,2, Khurshid Jahan3, Saria Tasnim4,5

  • 1Bangladesh Breastfeeding Foundation (BBF), Room # 197-200, Institute of Public Health (IPH), Mohakhali, Dhaka, Bangladesh. skroy1950@gmail.com.

Insights

Violations of Bangladesh's Breast-milk Substitute (BMS) Act are widespread, with retailers and health professionals promoting BMS products unethically. Urgent enforcement is needed to protect infant feeding practices and reduce child mortality.

Area of Science:

  • Public Health
  • Nutrition Policy
  • Child Health

Background:

  • Inadequate breastfeeding practices contribute to significant infant mortality and morbidity globally.
  • Bangladesh faces challenges with exclusive breastfeeding rates, necessitating regulatory measures.
  • The Breast-milk Substitute (BMS) Act of 2013 and its 2017 Rules were enacted to regulate BMS marketing.

Purpose of the Study:

  • To assess violations of the BMS Act, 2013, and Rules, 2017 in Bangladesh.
  • To identify the types, actors, and settings of BMS Act violations.
  • To raise awareness about the BMS Act among stakeholders and the public.

Main Methods:

  • A cross-sectional survey was conducted across eight divisions of Bangladesh.
  • Data collection involved retail outlets, pharmacies, baby-friendly hospitals, health professionals, and mothers.
  • Methods included structured interviews, direct observations, and document reviews using standardized protocols.

Main Results:

  • All surveyed retail outlets sold unregistered BMS products with promotional materials and health claims.
  • A significant percentage of doctors and nurses promoted BMS without medical indication.
  • Health facilities reported financial incentives from BMS manufacturers, and manufacturers established unauthorized breastfeeding corners.

Conclusions:

  • Extensive violations of the BMS Act and Rules were identified, indicating unethical promotion and distribution of BMS.
  • Health professionals in baby-friendly hospitals were implicated in these breaches, undermining breastfeeding.
  • Urgent monitoring and enforcement are crucial to protect infant health and uphold national regulations.
Abstract

Related Concept Videos

Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Good Manufacturing Practices01:26

Good Manufacturing Practices

Good Manufacturing Practices (GMP) constitute a foundational set of guidelines that ensure the production of safe, consistent, and high-quality products, particularly in industries such as pharmaceuticals, biotechnology, and food processing. These protocols encompass all aspects of production, from the sourcing of raw materials to the final distribution of the finished product.A core pillar of GMP is stringent hygiene and sanitation across all production environments. This includes routine...
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
Parental Care00:55

Parental Care

Many animals exhibit parental care behavior, including feeding, grooming, and protecting young offspring. Parental care is universal in mammals and birds, which often have young that are born relatively helpless. Several species of insects and fish, as well as some amphibians, also care for their young.